Hair loss medicine is moving faster right now than it has in thirty years.

Two investigational treatments for pattern hair loss posted positive late-stage trial results in the past twelve months. A third, an antibody designed with artificial intelligence, is working its way through early human dosing. Investors have noticed, and the comparison being made is to the early GLP-1 market: a very large group of men and women already paying out of pocket for treatments that do not work well enough.

The headlines are exciting.

But you do not have to wait for any of it. The most useful thing you can do for your hair this year is find out why it is falling out.

Hair loss is not one diagnosis

Thinning looks nearly identical from one person to the next and comes from completely different places.

Androgenetic alopecia, commonly called male or female pattern hair loss, is one possibility. It is not the only one. Shedding also shows up with low iron, thyroid disease, nutritional deficiencies, hormonal shifts, medications, rapid weight loss, illness, high stress and the postpartum period. Inflammatory and scarring alopecias sit in an entirely separate category and need a different approach, sometimes an urgent one, because a scarred follicle does not grow back.

Which is why the answer should not be the same prescription for everyone who walks through the door.

And there is a timing problem that trips people up. Hair sheds on a delay. What you are pulling out of the shower drain this week often traces back to something that happened to your body three months ago, which is why the story you tell in the exam room matters as much as the labs.

What is available today

Minoxidil is still the backbone of pattern hair loss treatment. Topical formulations are available without a prescription and have decades of use behind them.

Low-dose oral minoxidil is prescribed off label by clinicians for selected patients. Oral minoxidil is FDA approved for high blood pressure, not for hair loss, so it belongs in a conversation about your cardiovascular history, your other medications and what side effects you are willing to accept. Not everyone is a candidate.

Finasteride is FDA approved for male pattern hair loss. Dutasteride and spironolactone are used off label in appropriately selected patients, and the choice between them is driven by sex, age, pregnancy potential, blood pressure, potassium and what a patient is actually willing to take long term.

Compounded topicals have a place in specific situations. They are not automatically safer because they go on your scalp instead of down your throat. FDA has specifically cautioned that compounded topical finasteride can be absorbed systemically and has been associated with reported systemic adverse effects, in an April 2025 alert citing 32 adverse event reports received between 2019 and 2024, many describing symptoms that continued after the product was stopped [1]. Anyone who tells you a topical carries zero systemic risk is selling something.

Procedures still matter. PRP and PRF scalp injections and microneedling are used alongside medical therapy, not instead of a diagnosis.

What is coming next

Three programs are worth watching, and their progress is the reason this field suddenly looks different than it did two years ago.

But the direction is clear, and it is the first real movement this category has seen in a very long time.

Hair restoration works better as a strategy than as a single treatment

Medical hair restoration is rarely a choice between a medication and a procedure.

For the right patient it looks like correcting a deficiency that was found on labs, adding medical therapy matched to the type of hair loss, layering a topical, using PRP or PRF and microneedling to support the follicles that are still viable, and then photographing the scalp every three months so progress is measured instead of guessed at. Some of those pieces will not apply to you. That is the point of an evaluation.

Answer that one, and the treatment plan builds itself around the diagnosis instead of around whatever product is being advertised hardest that month.

Where to start

Navara Health offers medical hair loss consultations, targeted laboratory evaluation and individualized treatment planning for women and men dealing with thinning or heavy shedding. All consultations are virtual and available in eleven states: Texas, Arizona, Colorado, Connecticut, Florida, Iowa, New Mexico, Oklahoma, Vermont, Virginia and Washington. In-person clinic visits are reserved for procedures such as PRP, PRF and microneedling.

Recommendations depend on your history, your exam, your lab findings and the type of hair loss you have. Prescription treatment is not appropriate for everyone, and results vary from person to person.